Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Baltimore Marriott Waterfront

05 feb 2024 7:00 a.m. - 07 feb 2024 1:00 p.m.

700 Aliceanna Street , Baltimore, MD 21202

Global Pharmacovigilance and Risk Management Strategies Conference

Keynote Address!

February 5 | 8:40AM-9:25PM

Keynote Address

Session 1: Keynote: Personalized Medicine and the Pharmaceutical Industry

The Keynote has Been Released! Michael Ybarra, MD, Chief Medical Officer, PhRMA

Featured

Want to learn more about Global Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!

Continuing Education

Highlights & Features

Stay in the know with what's going on at the event

Today’s Baltimore is a place where good ideas and ambition are the currency that matter most. It’s a place where art is seen as a catalyst for conversation, food as a means of connection, and history as an opportunity for education. It’s an essential destination full of inclusive neighborhoods where all visitors will feel invited, welcomed, and seen. Click here to check out all the tour guides based on your interests.

Discover Baltimore!

Short Course or Primer

To keep you at the forefront.

24 ene 2024

Short Course:

Introduction to Statistics in Pharmacovigilance

04 feb 2024

Short Course:

Aggregate Safety Assessment Planning (ASAP) Process

27 feb 2024

Short Course:

Good Pharmacovigilance Practices (GVP) Operations Development – From Clinical Trial to Post Marketing

Comité del programa

  • James  Buchanan, PharmD
    James Buchanan, PharmD President
    Covilance LLC, United States
  • Mariette  Boerstoel-Streefland, MD, MBA, MS
    Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
    Bristol-Myers Squibb Company, United States
  • Barbara  Hendrickson, DrMed, MD
    Barbara Hendrickson, DrMed, MD Clinical Associate, Pediatric Infectious Diseases
    University of Chicago, United States
  • Scott  Janiczak, PharmD, MPH
    Scott Janiczak, PharmD, MPH Safety Evaluator, LCDR, Division of Pharmacovigilance I, OSE, CDER
    FDA, United States
  • Mamiko  Kasho
    Mamiko Kasho Executive Director, Global PV Management Dept., Global Safety HQs
    Eisai Co., Ltd., Japan
  • Susan  Kindig, JD, MD
    Susan Kindig, JD, MD Prior Executive Director, Medical and Drug Safety
    United States
  • Mengchun  Li, MD, MPA
    Mengchun Li, MD, MPA Senior Director, Clinical Research, Infectious Disease
    Merck & Co., Inc., United States
  • Joseph  Paradis, PharmD
    Joseph Paradis, PharmD Associate Director for Medication Error and Risk Management Initiatives, CDER
    FDA, United States
  • Mark  Perrott, PhD
    Mark Perrott, PhD Managing Partner
    Axian Consulting Ltd., United Kingdom
  • Sarah  Vaughan
    Sarah Vaughan Head of Vigilance Operations
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • Yijing (Hellen)  Zhang, MPharm
    Yijing (Hellen) Zhang, MPharm Executive Director, Global Patient Safety
    Beigene, China
  • Jeremy  Jokinen, PhD, MS
    Jeremy Jokinen, PhD, MS Vice President and Head, Safety Evidence and Sciences
    Bristol-Myers Squibb Company, United States
  • Annette S. Williams, MBA, RPh
    Annette S. Williams, MBA, RPh Vice President, Pharmacovigilance
    IQVIA, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.